An injectable contraceptive is under development in India, and U.S. companies are pursuing their own versions.

New injectable male contraceptives could offer long-lasting, reversible birth control as U.S. companies advance clinical trials.

Conversations around women’s health and pharmaceutical accountability are becoming far more urgent across the nation as lawsuits tied to the Depo-Provera birth control shot continue to grow. What ...

About 60 percent of American women of reproductive age are using a contraceptive method. More than 25 percent of them are using the pill. What about the men? For decades, researchers have been working ...

For millions of American romantic partners who aren't currently in the midst of actively trying to conceive a child together, or countless Americans who are single, the entire category of "birth ...

DMPA is available in two injectable forms: an intramuscular injection, marketed under the name Depo Provera, that can only be administered by a provider, and one that is injected just under the skin.

The decision comes as Pfizer faces lawsuits from more than 1000 women who say the company knew about the risks and didn’t warn them. The agency signed off last week on a label update for 2 versions of ...

Pfizer’s battle over the safety label for its birth control injection has finally come to a close. The pharma giant announced that the Food and Drug Administration approved its new safety warning ...

Recent litigation has accelerated nationwide after studies and regulatory developments raised concerns about a possible link between long-term use of the shot and meningioma tumors. Presented by Staff ...

Doctors said the meningiomas could be linked to the woman using the contraceptive injections — which she had been receiving regularly for 21 years, in order to avoid getting monthly periods "I'd take ...